Adiponectin, visceral fat, oxidative stress, and early macrovascular disease

The coronary artery risk development in young adults study

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Objective: Adiponectin is a collagen-like product of visceral fat that offers apparent protection against macrovascular disease. We evaluated the relationships of concentrations of adiponectin with oxidative stress and the major risk factors for and/or the presence of macrovascular disease. Research Methods and Procedures: Adiponectin was measured by radioimmunoassay in serum from 3045 fasting participants (ages 33 to 45) of the Coronary Artery Risk Development in Young Adults Study. Cross-sectional correlation of the concentrations of adiponectin with F2-isoprostane concentrations (a marker of systemic oxidative damage), coronary artery calcification (CAC; an estimate of early macrovascular disease), and several macrovascular risk factors was analyzed. Results: F2-isoprostanes and CAC were unrelated to adiponectin after minimal adjustment for gender, race, and center. After additional adjustment for insulin resistance and waist circumference and other macrovascular risk factors, adiponectin correlated positively with high-density lipoprotein-cholesterol (p < 0.0001), F2-isoprostanes (p < 0.0001), and CAC (less strongly, p < 0.01) and negatively with triglycerides (p < 0.0001) and C-reactive protein (marking inflammation, p = 0.01). Discussion: Although these data are consistent with reduced cardiovascular disease risk imparted by adiponectin, the higher circulating levels of adiponectin present with oxidative stress and CAC (adjusting for waist and insulin resistance) may indicate an enhanced adiponectin secretory response of adipose tissue to the metabolic environment present in the early development of macrovascular disease. Thus, the elevated levels of adiponectin may comprise an attempt to alleviate risk for additional development and progression of macrovascular disease in an at-risk environment.

Original languageEnglish (US)
Pages (from-to)319-326
Number of pages8
JournalObesity
Volume14
Issue number2
DOIs
StatePublished - Feb 1 2006

Fingerprint

Intra-Abdominal Fat
Adiponectin
Coronary Artery Disease
Young Adult
Oxidative Stress
F2-Isoprostanes
Insulin Resistance
Coronary Vessels
Waist Circumference
C-Reactive Protein
HDL Cholesterol
Radioimmunoassay
Disease Progression
Adipose Tissue
Fasting
Triglycerides
Cardiovascular Diseases
Collagen
Inflammation

Keywords

  • Adiponectin
  • Macrovascular disease
  • Oxidative stress
  • Visceral fat

Cite this

@article{0426736821b84ad3a62dd4e40bb8a7d2,
title = "Adiponectin, visceral fat, oxidative stress, and early macrovascular disease: The coronary artery risk development in young adults study",
abstract = "Objective: Adiponectin is a collagen-like product of visceral fat that offers apparent protection against macrovascular disease. We evaluated the relationships of concentrations of adiponectin with oxidative stress and the major risk factors for and/or the presence of macrovascular disease. Research Methods and Procedures: Adiponectin was measured by radioimmunoassay in serum from 3045 fasting participants (ages 33 to 45) of the Coronary Artery Risk Development in Young Adults Study. Cross-sectional correlation of the concentrations of adiponectin with F2-isoprostane concentrations (a marker of systemic oxidative damage), coronary artery calcification (CAC; an estimate of early macrovascular disease), and several macrovascular risk factors was analyzed. Results: F2-isoprostanes and CAC were unrelated to adiponectin after minimal adjustment for gender, race, and center. After additional adjustment for insulin resistance and waist circumference and other macrovascular risk factors, adiponectin correlated positively with high-density lipoprotein-cholesterol (p < 0.0001), F2-isoprostanes (p < 0.0001), and CAC (less strongly, p < 0.01) and negatively with triglycerides (p < 0.0001) and C-reactive protein (marking inflammation, p = 0.01). Discussion: Although these data are consistent with reduced cardiovascular disease risk imparted by adiponectin, the higher circulating levels of adiponectin present with oxidative stress and CAC (adjusting for waist and insulin resistance) may indicate an enhanced adiponectin secretory response of adipose tissue to the metabolic environment present in the early development of macrovascular disease. Thus, the elevated levels of adiponectin may comprise an attempt to alleviate risk for additional development and progression of macrovascular disease in an at-risk environment.",
keywords = "Adiponectin, Macrovascular disease, Oxidative stress, Visceral fat",
author = "Steffes, {Michael W} and Gross, {Myron D} and Lee, {Duk Hee} and Schreiner, {Pamela J} and {Jacobs Jr}, {David R}",
year = "2006",
month = "2",
day = "1",
doi = "10.1038/oby.2006.41",
language = "English (US)",
volume = "14",
pages = "319--326",
journal = "Obesity",
issn = "1930-7381",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Adiponectin, visceral fat, oxidative stress, and early macrovascular disease

T2 - The coronary artery risk development in young adults study

AU - Steffes, Michael W

AU - Gross, Myron D

AU - Lee, Duk Hee

AU - Schreiner, Pamela J

AU - Jacobs Jr, David R

PY - 2006/2/1

Y1 - 2006/2/1

N2 - Objective: Adiponectin is a collagen-like product of visceral fat that offers apparent protection against macrovascular disease. We evaluated the relationships of concentrations of adiponectin with oxidative stress and the major risk factors for and/or the presence of macrovascular disease. Research Methods and Procedures: Adiponectin was measured by radioimmunoassay in serum from 3045 fasting participants (ages 33 to 45) of the Coronary Artery Risk Development in Young Adults Study. Cross-sectional correlation of the concentrations of adiponectin with F2-isoprostane concentrations (a marker of systemic oxidative damage), coronary artery calcification (CAC; an estimate of early macrovascular disease), and several macrovascular risk factors was analyzed. Results: F2-isoprostanes and CAC were unrelated to adiponectin after minimal adjustment for gender, race, and center. After additional adjustment for insulin resistance and waist circumference and other macrovascular risk factors, adiponectin correlated positively with high-density lipoprotein-cholesterol (p < 0.0001), F2-isoprostanes (p < 0.0001), and CAC (less strongly, p < 0.01) and negatively with triglycerides (p < 0.0001) and C-reactive protein (marking inflammation, p = 0.01). Discussion: Although these data are consistent with reduced cardiovascular disease risk imparted by adiponectin, the higher circulating levels of adiponectin present with oxidative stress and CAC (adjusting for waist and insulin resistance) may indicate an enhanced adiponectin secretory response of adipose tissue to the metabolic environment present in the early development of macrovascular disease. Thus, the elevated levels of adiponectin may comprise an attempt to alleviate risk for additional development and progression of macrovascular disease in an at-risk environment.

AB - Objective: Adiponectin is a collagen-like product of visceral fat that offers apparent protection against macrovascular disease. We evaluated the relationships of concentrations of adiponectin with oxidative stress and the major risk factors for and/or the presence of macrovascular disease. Research Methods and Procedures: Adiponectin was measured by radioimmunoassay in serum from 3045 fasting participants (ages 33 to 45) of the Coronary Artery Risk Development in Young Adults Study. Cross-sectional correlation of the concentrations of adiponectin with F2-isoprostane concentrations (a marker of systemic oxidative damage), coronary artery calcification (CAC; an estimate of early macrovascular disease), and several macrovascular risk factors was analyzed. Results: F2-isoprostanes and CAC were unrelated to adiponectin after minimal adjustment for gender, race, and center. After additional adjustment for insulin resistance and waist circumference and other macrovascular risk factors, adiponectin correlated positively with high-density lipoprotein-cholesterol (p < 0.0001), F2-isoprostanes (p < 0.0001), and CAC (less strongly, p < 0.01) and negatively with triglycerides (p < 0.0001) and C-reactive protein (marking inflammation, p = 0.01). Discussion: Although these data are consistent with reduced cardiovascular disease risk imparted by adiponectin, the higher circulating levels of adiponectin present with oxidative stress and CAC (adjusting for waist and insulin resistance) may indicate an enhanced adiponectin secretory response of adipose tissue to the metabolic environment present in the early development of macrovascular disease. Thus, the elevated levels of adiponectin may comprise an attempt to alleviate risk for additional development and progression of macrovascular disease in an at-risk environment.

KW - Adiponectin

KW - Macrovascular disease

KW - Oxidative stress

KW - Visceral fat

UR - http://www.scopus.com/inward/record.url?scp=33748157466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748157466&partnerID=8YFLogxK

U2 - 10.1038/oby.2006.41

DO - 10.1038/oby.2006.41

M3 - Article

VL - 14

SP - 319

EP - 326

JO - Obesity

JF - Obesity

SN - 1930-7381

IS - 2

ER -